View on Pubmed.gov 35429991 | View on doi.org 10.1038/s41420-...
Research progress of Nedd4L in cardiovascular diseases.
- Department of Cardiology, First Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Cardiology, First Hospital of China Medical University, Shenyang, Liaoning, China. yxsun@cmu.edu.cn. Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China. yxsun@cmu.edu.cn.
- Department of Cardiology, First Hospital of China Medical University, Shenyang, Liaoning, China. yzhang02@cmu.edu.cn. Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China. yzhang02@cmu.edu.cn.
- Department of Cardiology, First Hospital of China Medical University, Shenyang, Liaoning, China. njzhang@cmu.edu.cn.
- Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China. njzhang@cmu.edu.cn.
Abstract
Post-translational modifications (PTMs) are a covalent processing process of proteins after translation. Proteins are capable of playing their roles only after being modified, so as to maintain the normal physiological function of cells. As a key modification of protein post-translational modification, ubiquitination is an essential element, which forms an enzyme-linked reaction through ubiquitin-activating enzyme, ubiquitin binding enzyme, and ubiquitin ligase, aiming to regulate the expression level and function of cellular proteins. Nedd4 family is the largest group of ubiquitin ligases, including 9 members, such as Nedd4-1, Nedd4L (Nedd4-2), WWP1, WWP2, ITCH, etc. They could bind to substrate proteins through their WW domain and play a dominant role in the ubiquitination process, and then participate in various pathophysiological processes of cardiovascular diseases (such as hypertension, myocardial hypertrophy, heart failure, etc.). At present, the role of Nedd4L in the cardiovascular field is not fully understood. This review aims to summarize the progress and mechanism of Nedd4L in cardiovascular diseases, and provide potential perspective for the clinical treatment or prevention of related cardiovascular diseases by targeting Nedd4L.
References
Int J Mol Sci. 2020 May 29;21(11):
Nat Rev Nephrol. 2018 Mar;14(3):185-201
J Clin Invest. 1999 Mar;103(5):667-73
Eur J Hum Genet. 2001 Dec;9(12):922-30
Cited by 22 citations (total)
Journal Article Review Research Support, Non-U.S. Gov't
Mechanisms of RNA and Protein Quality Control and Their Roles in Cellular Senescence and Age-Related Diseases.
Electronic publication date December 27, 2022
Donghee Kang [...] Jae-Seon Lee et al.
Cellular senescence, a hallmark of aging, is defined as irreversible cell cycle arrest in response to various stimuli. It plays...
Journal Article Review
Targeting Atherosclerosis via NEDD4L Signaling-A Review of the Current Literature.
Electronic publication date March 26, 2025
Lucas Fornari Laurindo [...] Sandra Maria Barbalho et al.
Cardiovascular diseases are the primary cause of mortality worldwide. In this scenario, atherosclerotic cardiovascular outcomes dominate since their incidence increases...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
Specialties
- •
Copyright
© 2022. The Author(s).